EGF and cancer: An issue arises from blocking endocytic processes, which could enhance the activation of growth‐promoting signaling pathways in cancer cells, potentially leading to tumor growth and treatment resistance.[13, 14] In HT29 cells, EGFR phosphorylation increased upon EGF stimulation.